International Business Machines Corp Jumps to Fight Zika Virus; Here’s How

The tech giant has moved ahead in the scheme of sorting out the correct molecule for the treatment of Zika virus

Zika virus has gradually covered the whole globe in its epidemic, increasing the threat day-by-day. After its inception in Brazil last year, it has now shown its presence in a majority of the countries. World Health Organization (WHO) has already declared it as a medical emergency and multiple pharmaceutical companies and Biotechs are working hard to sort out the investigational molecule for its management and treatment.

To date, there is no news regarding the manufacturing of any medicine or vaccine, so far the cure is the preventative measures only. The medical community has reservations about the time taken by the pharmaceutical companies to develop a vaccine for this virus as it needs to be cured on an urgent basis.

International Business Machine Corp. (NYSE:IBM) in collaboration with Rutgers University is working on a project to identify the potential drugs and their role in the management and treatment of Zika virus. The University will use IBM’s World Community Grid to look into the options of minimizing the time duration needed in identifying the molecule.The volunteers in a blink of an eye can manage to send information to the researchers, while busy in their daily normal activities.

The main aim of the community grid is to involve the professionals on a combined tech platform while working on their laptops, desktops, or android phones and tablets to provide drug-related research or information into a virtual supercomputer.

This mega project is named “OpenZika,” which comprises highly-qualified researchers and scientists having expertise in the “Virtual” experiments to dig out quick and trusted treatment for the patients suffering from the Zika virus.

The role of the OpenZika virus is vital in the search of the novel molecule for the treatment of Zika virus ailments. The high-tech program will scan the drugs and other investigational molecules in relation to the pattern of Zika protein structures, along with West Nile virus, and Dengue. If any molecule shows productivity in inhibiting the role of the virus, it will be quickly shared with the research community and pharmaceutical industry to validate the calculations.

Rutgers’ New Jersey Medical School Rutgers research teaching specialist at Alex Perryman said: “Instead of having to wait a number of years, even decades potentially, to test all these compounds in order to find a few that could form the basis of antiviral drugs to cure Zika, we will perform these initial tests in a matter of months, just by using idle computing power that would otherwise go to waste.”

OpenZika mega project Grid is based in Brazil and led by the Federal University of Goiás, and with support from Brazil’s Oswaldo Cruz Foundation (Fiocruz); Rutgers University’s New Jersey Medical School; Collaborations Pharmaceuticals, Inc.; and the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego.

In 2004, IBM developed the World Community Grid to help out the researchers in their research work in minimum timeframe using the supercomputing strategy. The tech platform provides supercomputing facility free of cost on the researchers’ android devices.

IBM’s research team is looking for volunteers having a laptop, desktop, or any android device for the OpenZika program. Any personnel can join the program without any obligation and cost. The volunteers just have to download and run the program on their Windows, Mac, Linux, or Android devices

Approximately, there are three million computers and android devices attached to the program, making it one of the largest tech platforms globally. Before the Zika virus program, the grid has also worked on more than 12 projects since its inception with an estimated revenue generation of $500 million.

The majority of people and companies of multiple origins have started working in their idle computer time on the research topic, its notifications, and interacting with the latest information in the Grid.

Many of the researchers working in collaboration with the institutes registered in the OpenZika project are of the opinion that they are getting tons of data from the Grid and it is helping them out to look for multiple options for the cure of the virus.

The role of the supercomputers is vital in the early assessment of tons of data within minutes, whereas on the traditional computers, it will take days and months to study the clinical information.

To maintain the performance of such huge computational grids, researchers are using virtual screening tool known as AutoDock VINA developed by Olson Laboratory at the Scripps Research Institute.

Zika Virus

Mosquitoes are the main source of transmission in the human population. It is also spreading via sexual contact. In the US, majority cases have been reported as sexually transmitted. Zika virus is also related to the development of microcephaly and Guillain-Barre syndrome (GBS). Both the diseases are chronic and can lead to death.

Cognitive Computing

IBM is playing its vital role in the field of servers and mainframes. The main emphasis of the tech company is in the banking and airline sector. In addition, it is expanding its portfolio in the fields of cybersecurity and cloud.

In 2011, with the tremendous and exceptional success of Watson artificial intelligence program, it beat human players during a game show “Jeopardy.”

Before Watson, IBM AI program “Deep Blue” proved its superiority in 1995 by competing in computing program in every possible way. In the last decade, the tech company has faced a major decline in sales, leading to massive downsizing.

Role In Medicine

In 2015, the company has made a consortium with Mars Inc. for the improvement of food hygiene, clinical studies on the bacterial, fungi, and multiple types of viruses along with their growth pattern in different environments.

Memorial Sloan-Kettering Cancer Center and IBM collaborated on the usage of Watson for medical researchers and physicians to get better access to the pathology and diagnostics of different diseases specifically targeting the oncology portfolio.

Watson is capable of going through millions of MRIs, CT scans, CAT scan images in order to ascertain doctors the right diagnosis in minimum time.

IBM has fierce competition in the cognitive field from Google, Apple, and Facebook. These tech companies have invested hefty amounts in different platforms assisting the healthcare and pharma industry.

The pharmaceutical companies involved in the development of vaccine includes Sanofi SA (NYSE:SNY), Inovio Pharmaceuticals Inc. (NASDAQ:INO), GlaxoSmithKline plc (NYSE:GSK). The normal vaccine takes a decade for the development. The companies are working to link the vaccine manufacturing with the dengue and West Nile virus.

IBM’s New Achievement

IBM is working very diligently on the future aspect of integrating technical devices with the medical data. This will enhance the ability and exposure of the medical community and will save ample amount of time. In the recent development, IBM and the Institute of Bioengineering and Nanotechnology (IBN) based in Singapore in a mutual collaboration developed a macromolecule, which has the properties to fight against the epidemic viral diseases such as Ebola, Zika, dengue, herpes, and multiple types of influenza.

The mode of action of the molecule is divided into three segments, which includes inhibiting the virus to impact its role on health cells and tissues, preventing the replication process of the virus and to increase the immunity system of the individual to be capable of destroying the virus.

Till date in the laboratory, the safety and effectiveness of the magic molecule proved it to be lethal against the Ebola, dengue, and herpes simplex viruses have met its primary endpoints

In addition, the new macromolecule has the ability to compete with the mutations as they occur in the virus with the passage of time.

Mutation of the Zika virus is the main problem that has created hindrance in the development of the vaccine in a short span of time. Both IBM and IBN were working on the Zika virus since its reappearance last year in Brazil. Both companies are now planning to contact with pharmaceutical industry to start clinical studies on humans.

Furthermore, the tech giant is also helping the government to control the viral epidemics via its highly-sophisticated tech platform. The tech company has given citizen engagement and analytics system in Sierra Leone. By virtue of this software, the patients suffering from the Ebola virus can easily communicate their healthcare issues and developments to concerned authorities.

IBM has also provided opinion-based heat maps to identify the outbreaks of the disease helping out the scientists, researchers, and government officials to work out on the specific area of the outbreak.

We have studied investments from Netflix, new contracts signed by Orbital, SolarCity earnings report and their negotiation with Tesla for the acquisition of the Powerball battery, the problems that ARCH coal is facing, how IBM is investing in the treatment of the Zika virus, how Moon Express is planning to mine minerals in the moon, and how Citigroup is engaged in commodity trading.

We follow a lot Tesla here, from the fundamental analysis and from the technical as well. See how the Chevy Bolt and the Tesla 3 are dimensioning the evolution of the price of this shares and how this could affect technical analysis, and how the Autopilot functionality is working: the evolution of the Autopilot software has always influenced the prices of their stocks. Tesla Model S 70D is considered the “car of the century”, not by us of course, but we are interested to see how these awards affect the evolution of the stocks. Tesla and other companies signed an agreement so that autobraking became the standard in 2022. A trend in the automobile industry started by Mercedes Benz and Tesla, is having a platform to sell pre-owned vehicles: now General Motors is joining that trend as well.

We have studies how the stock slump of GoPro should be considered not only from the view of technical analysis. Also, check the functionality from Facebook, the “login approval” and if it really protects users or other interests. The reports from Volkswagen about their very low injury claims, how now other companies in China can use the name “IPhone” apart from Apple. We continue in China to learn about the Marketplace Alliance Program from Alibaba, and the joint investment in CloudFlare from Google Inc, Microsoft Corporation, Qualcomm, and Baidu.

About Google, a company we follow a lot here, I want to see how they have entered in the batteries market and how this will affect their current projects and the evolution of the stocks. Interesting are the Chrome updates to decrease CPU usage.

We analyze the effects of the position of Disney in the dispute between Netflix and Time Warner, so we can understand how Disney is shifting its business after selling its stake in Fusion.

We discuss briefly how Oracle adressed the changes in the cloud-computing industry, why Morgan Stanley is optimistic after the pandemic and the Brexit, the divestment in Dell regarding Perot Systems, and the effects of the huge minimum wage rise in Costco. Chipotle is cutting the executive compensation, the issues that BP is facing, what happens with Macy´s earnings and how fundamental analysis can be done in those cases. About Apple, we analyze the effect of the launch of this product Apple Watch where sales performed very irregularly.

Photo of author

Author D Laidler

I am David, economist, originally from Britain, and studied in Germany and Canada. I am now living in the United States. I have a house in Ontario, but I actually never go.  I wrote some books about sovereign debt, and mortgage loans. I am currently retired and dedicate most of my time to fishing. There were many topics in personal finances that have currently changed and other that I have never published before. So now in Business Finance, I found the opportunity to do so. Please let me know in the comments section which are your thoughts. Thank you and have a happy reading.

Thank you for visiting businessfinancenews.com

Leave a Comment

Business Finance

About Us

Business Finance News is a brand oriented to business owners and dedicated to analyzing and comparing the cost and conditions of B2B procurement of goods and services through free quotes delivered by business partners.

Contact

Address 5050 Quorum Drive, (75254) Dallas TX

telephone 844-368-6072

DISCLAIMER

A personal loan is a medium term loan with a fixed interest rate that is repaid in equal monthly payments and it's usually limited to 24 months. Loan offers and eligibility depend on your individual credit profile. Our lenders can help you obtain as much as $3,000 depending on the lender, your state and your financial situation.

The owner and operator of businessfinancenews.com is not a lender and is not involved into making credit decisions associated with lending or making loan offers. Instead, the website is designed only for a matching service, which enables the users contact with the lenders and third parties. The website does not charge any fees for its service, nor does it oblige any user to initiate contact with any of the lenders or third parties or accept any loan product or service offered by the lenders. All the data concerning personal loan products and the industry is presented on the website for information purposes only.

Businessfinancenews.com does not endorse any particular lender, nor does it represent or is responsible for the actions or inactions of the lenders. Businessfinancenews.com does not collect, store or has access to the information regarding the fees and charges associated with the contacting lenders and/or any loan products. Online personal loans are not available in all the states. Not all the lenders in the network can provide the loans up to $3,000. Businessfinancenews.com cannot guarantee that the user of the website will be approved by any lender or for any loan product, will be matched with a lender, or if matched, will receive a personal loan offer on the terms requested in the online form. The lenders may need to perform credit check via one or more credit bureaus, including but not limited to major credit bureaus in order to determine credit reliability and the scopes of credit products to offer. The lenders in the network may need to perform additional verifications, including but not limited to social security number, driver license number, national ID or other identification documents. The terms and scopes of loan products vary from lender to lender and can depend on numerous factors, including but not limited to the state of residence and credit standing of the applicant, as well as the terms determined by each lender individually. 

APR REPRESENTATIVE

APR (Annual Percentage Rate) is the loan rate calculated for the annual term. Since businessfinancenews.com is not a lender and has no information regarding the terms and other details of personal loan products offered by lenders individually, businessfinancenews.com cannot provide the exact APR charged for any loan product offered by the lenders. The APRs greatly vary from lender to lender, state to state and depend on numerous factors, including but not limited to the credit standing of an applicant. Additional charges associated with the loan offer, including but not limited to origination fees, late payment, non-payment charges and penalties, as well as non-financial actions, such as late payment reporting and debt collection actions, may be applied by the lenders. These financial and non-financial actions have nothing to do with businessfinancenews.com, and businessfinancenews.com has no information regaining whatsoever actions may be taken by the lenders. All the financial and non-financial charges and actions are to be disclosed in any particular loan agreement in a clear and transparent manner. The APR is calculated as the annual charge and is not a financial charge for a personal loan product. 

Late Payment Implications

It is highly recommended to contact the lender if late payment is expected or considered possible. In this case, late payment fees and charges may be implied. Federal and state regulations are determined for the cases of late payment and may vary from case to case. All the details concerning the procedures and costs associated with late payment are disclosed in loan agreement and should be reviewed prior to signing any related document. 

Non-payment Implications

Financial and non-financial penalties may be implied in cases of non-payment or missed payment. Fees and other financial charges for late payment are to be disclosed in loan agreement. Additional actions related to non-payment, such as renewals, may be implied upon given consent. The terms of renewal are to be disclosed in each loan agreement individually. Additional charges and fees associated with renewal may be applied. 

Debt collection practices and other related procedures may be performed. All the actions related to these practices are adjusted to Fair Debt Collection Practices Act regulations and other applicable federal and state laws in order to protect consumers from unfair lending and negative borrowing experience. The majority of lenders do not refer to outside collection agencies and attempt to collect the debt via in-house means. 

Non-payment and late payment may have negative impact on the borrowers’ credit standing and downgrade their credit scores, as the lenders may report delinquency to credit bureaus, including but not limited to Equifax, Transunion, and Experian. In this case the results of non-payment and late payment may be recorded and remain in credit reports for the determined amount of time.